INTRODUCTION: Patients with Inflammatory Bowel Disease (IBD) face the prospect of long-term immunosuppression to manage their disease. As a result, vaccinations are of heightened importance in order to reduce rates of serious, preventable infections. At our institution, IBD patients may follow up with one of three gastroenterology (GI) providers: IBD specialists, GI Fellows and General GI providers. The objective of this study is to identify whether type of GI provider has an effect on the rates of vaccinations for IBD patients. METHODS: This is a retrospective case control study of vaccination rates of patients with a confirmed diagnosis of IBD who had a documented outpatient follow-up with a GI provider at Montefiore Medical Center between 1/1/18 and 12/31/19. Data collected included patient demographics, IBD type, treatment regimen, insurance and GI provider followed. Information regarding vaccination status was gathered for the seven recommended inactivated vaccines listed in the American College of Gastroenterology’s 2017 Guidelines on Preventative Care in IBD including Influenza, Tetanus/Diphtheria/Pertussis (TDaP), Hepatitis A (HAV), Hepatitis B (HBV), Pneumococcus (PCV13 and PPSV23), Meningococcus, and Human Papillomavirus (HPV). Statistical analyses were then done to determine whether there were differences in the rates of being current for each of the seven vaccinations among patients who followed up with different GI providers. RESULTS: Out of 338 patients identified, 65 (19.2%) followed up with a GI fellow, 110 (32.5%) followed up with a general GI provider, and 163 (48.2%) followed up with an IBD specialist (Table 1). HBV was the only vaccine where there was a significant difference in vaccination rate by type of GI provider (Table 2). Multivariate analysis showed that patients who followed up with IBD specialists and GI fellows were more likely to be vaccinated for HBV than patients who followed up with general GI providers (OR = 2.55, P = 0.003 and OR = 2.73, P = 0.007 respectively [Table 3]). CONCLUSION: The type of GI provider only impacted rates of vaccination for the HBV vaccination for IBD patients in this study. For the HBV vaccination, IBD specialists and GI fellows outperformed general GI providers. Further studies should be done to better understand what factors influence vaccination rates for IBD patients.Table 1.: Demographic characteristicsTable 2.: a. Patients between ages 18 and 27 were included in this cohort (n = 50) as these vaccines were age-dependent b. P-values represent univariate chi-squared analysisTable 3.: a. Regression models adjusted for age, sex, race, IBD diagnosis, immunosuppression status and insurance in addition to type of GI provider